Cutler Group’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,200
Closed -$12K 4244
2023
Q2
$12K Sell
1,200
-3,000
-71% -$57.8K ﹤0.01% 2159
2023
Q1
$31K Buy
4,200
+1,200
+40% +$26.6K ﹤0.01% 1659
2022
Q4
$13K Sell
3,000
-2,000
-40% -$45.2K ﹤0.01% 2535
2022
Q3
$6K Hold
5,000
﹤0.01% 3547
2022
Q2
$20K Buy
+5,000
New +$125K ﹤0.01% 2681
2021
Q4
Sell
-6,500
Closed -$7K 5929
2021
Q3
$7K Buy
+6,500
New +$234K ﹤0.01% 4239
2020
Q2
Sell
-3,200
Closed -$26K 4778
2020
Q1
$26K Buy
+3,200
New +$133K ﹤0.01% 2138
2019
Q4
Sell
-1,800
Closed -$16K 4491
2019
Q3
$16K Sell
1,800
-7,200
-80% -$292K ﹤0.01% 2338
2019
Q2
$114K Sell
9,000
-4,900
-35% -$245K 0.01% 1026
2019
Q1
$126K Buy
13,900
+8,700
+167% +$431K 0.01% 882
2018
Q4
$68K Buy
5,200
+700
+16% +$41.1K 0.01% 1298
2018
Q3
$20K Buy
+4,500
New +$324K ﹤0.01% 2239
2018
Q2
Sell
-2,200
Closed -$5K 4749
2018
Q1
$5K Buy
+2,200
New +$64K ﹤0.01% 3302
2017
Q3
Sell
-3,500
Closed -$9K 6556
2017
Q2
$9K Buy
+3,500
New +$67.8K ﹤0.01% 4281

Other funds holding RGNX